Homograft conduit failure in infants is not due to somatic outgrowth

Journal of Thoracic and Cardiovascular Surgery

Volumn 124, Issue 1, 2002, Pages 88-96

  Wells, Winfield J ^a   Arroyo Jr , Hector ^a   Bremner, Ross M ^a   Wood, John ^a   Starnes, Vaughn A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; ANGIOGRAPHY; AORTOPULMONARY SEPTAL DEFECT; ARTICLE; CHILD; CLINICAL ARTICLE; CONGENITAL HEART MALFORMATION; FALLOT TETRALOGY; HEART RIGHT VENTRICLE OUTFLOW TRACT; HISTOLOGY; HUMAN; INFANT; PRIORITY JOURNAL; REOPERATION;

EID: 0036657881     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2002.121158     Document Type: Article

References (22)

1. Gerestein CG, Takkenberg JJM, Oei FBS, Cromme-Dijkhuis AH, Spitaels SEC, et al. Right ventricular outflow tract reconstruction with an allograft conduit. Ann Thorac Surg. 2001;71:911-8.
2. Forbes JM, Shah AS, St Louis JD, Jaggers JJ, Ungerleider RM. Cryopreserved Homografts in the pulmonary position: determinants of durability. Ann Thorac Surg. 2001;71:54-40.
3. Bielefeld MR, Bishop DA, Campell DN, Mitchell MB, Grover FL, Clarke DR. Reoperative homograft right ventricular outflow tract reconstruction. Ann Thorac Surg. 2001;71:482-8.
4. Caldarone CA, McCrindle BW, Van Arsdell GS, Coles JG, Webb G, Freedom RM, et al. Independent factors associated with longevity of prosthetic pulmonary valves and valved conduits. J Thorac Cardiovasc Surg. 2000;120:1022-31.
5. Tweddell JS, Pelech AN, Frommelt PC, Mussatto KA, Wyman JD, et al. Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease. Circulation. 2000;102(suppl):III-130-5.
6. Niwaya K, Knott-Craig, CJ, Lane MM, Chandrasekaren K, Overholt ED, Elkins RC. Cryopreserved homograft valves in the pulmonary position: risk analysis for intermediate-term failure. J Thorac Cardiovasc Surg. 1999;117:141-7.
7. Stark J, Bull C, Stajevic M, Jothi M, Elliot M, de Leval M. Fate of subpulmonary homograft conduits: determinants of late homograft failure. J Thorac Cardiovasc Surg. 1998;115:506-16.
8. Bando K, Danielson GK, Schaff HV, Mair DD, Julsrud PR, Puga FJ. Outcome of pulmonary and aortic homografts for right ventricular outflow tract reconstruction. J Thorac Cardiovasc Surg. 1995;109: 509-18.
9. Cochran RP, Kunzelman KS. Cryopreservation does not alter antigenic expression of aortic allografts. J Surg Res. 1989;46:597-9.
10. Neves JP, Gulbenkian S, Ramos T, Martins AP, Caldas MC, Mascarenhas R, et al. Mechanisms underlying degeneration of cryopreserved vascular homografts. J Thorac Cardiovasc Surg. 1997;113: 1014-21.
11. Hawkins JA, Breinholt JP, Lambert LM, Fuller TC, Profaizer T, McGough EC, et al. Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients. J Thorac Cardiovasc Surg. 2000;119:324-30.
12. Shaddy RE, Hunter DD, Osborn KA, Lambert LM, Minich LL, Hawkins JA, et al. Prospective analysis of HLA immunogenicity of cryopreserved valved allografts used in pediatric heart surgery. Circulation. 1996;94:1063-7.
13. Hoekstra FME, Witvliet M, Knoop CY, Wassner C, Bogers C, Weimar W, et al. Immunogenic human leukocyte antigen class II antigens on human cardiac valves induce specific alloantibodies. Ann Thorac Surg. 1998;66:2022-6.
14. Hoekstra F, Witvliet M, Knoop C, Akkersdijk G, Jutte N, Boggers A, et al. Donor-specific anti-human leukocyte antigen class I antibodies after implantation of cardiac valve allografts. J Heart Lung Transplant. 1997;16:570-2.
15. Rajani B, Mee RB, Ratliff NB. Evidence for rejection of homograft cardiac valves in infants. J Thorac Cardiovasc Surg. 1998;115:111-7.
16. Hoekstra F, Knoop C, Vaessen L, Wassenaar C, Jutte N, Bos E, et al. Donor-specific cellular immune response against human cardiac valve allografts. J Thorac Cardiovasc Surg. 1996;112:281-6.
17. Legare JF, Lee TDG, Creaser K, Ross DB. T lymphocytes mediate leaflet destruction and allograft valve failure in rats. Ann Thorac Surg. 2000;70:1238-45.
18. Motomura N, Imakita M, Yutani C, Kitoh Y, Kawashima Y, Oka T. Histological change in cryopreserved rat aortic allograft. J Cardiovasc Surg. 1995;36:53-60.
19. Sano S, Karl TR, Mee RBB. Extracardiac valved conduits in the pulmonary circuit. Ann Thorac Surg. 1991;52:285-90.
20. Shaddy RE, Lambert LM, Fuller TC, Profaizer, Thompson DD, Baker SI, et al. Prospective randomized trial of azathioprine in cryopreserved valved allografts in children. Ann Thorac Surg. 2001;71:43-8.
21. Goldstein S, Clarke DR, Walsh SP, Black KS, O'Brien MF. Transpecies heart valve transplantation: Advanced studies of a bioengineered xeno-graft. Ann Thorac Surg. 2000;70:1962-9.
22. Sodian R, Hoerstrup SP, Sperling JS, Daebritz S, Martin DP, Moran AM, et al. Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation. 2000;102(suppl):III-22-9.